As life sciences organizations accelerate digital transformation, Artificial Intelligence is no longer a future concept - it is an operational imperative. This keynote will explore how AI is reshaping GxP environments by driving smarter decision-making, enhancing data integrity, and enabling continuous validation across regulated systems. Attendees will gain a clear, practical perspective on how AI can be deployed responsibly within the constraints of FDA, EMA, and global regulatory expectations, while maintaining compliance, audit readiness, and patient safety.

Drawing on real-world industry experience, this session will highlight how organizations can move beyond experimentation to scalable, compliant AI adoption. From predictive quality and intelligent automation to risk-based validation and CSA-aligned strategies, the keynote will provide a roadmap for harnessing AI as a strategic enabler—not just a technology upgrade. Leaders will leave with actionable insights on governance, implementation, and value realization, empowering them to confidently integrate AI into their GxP landscape and unlock measurable business and compliance outcomes.